Corentec Co

Corentec Co CROIC

The Cash Return on Invested Capital (CROIC) of Corentec Co (104540.KQ) as of Oct 19, 2026 is 27.59 %. In the previous year, Cash Return on Invested Capital (CROIC) was -12.95 % — a change of -313.10% (higher).

CROIC

27.59 %

YoY

-313.10%

Last updated:

Cash Return on Invested Capital (CROIC) of Corentec Co is 2025 27.59 % . Cash Return on Invested Capital (CROIC) of Corentec Co was 2024 -12.95 % . It decreases by -313.10% higher compared to the previous year.

The Corentec Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
2.69 KRW
Jan 1, 2019
1.33 KRW
Jan 1, 2020
-12.59 KRW
Jan 1, 2021
-4.43 KRW
Jan 1, 2022
4.53 KRW
Jan 1, 2023
-10.11 KRW
Jan 1, 2024
-12.95 KRW
Jan 1, 2025
27.59 KRW
The Corentec Co CROIC history
YEARCROICYoY
27.59 %-313.10%
-12.95 %+28.05%
-10.11 %-323.38%
4.53 %-202.07%
-4.43 %-64.79%
-12.59 %-1,049.44%
1.33 %-50.73%
2.69 %-125.77%
-10.45 %-9.49%
-11.54 %+149.59%
-4.62 %-40.66%
-7.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Cash Return on Invested Capital (CROIC) of Corentec Co is 27.59 % in 2025.

Cash Return on Invested Capital (CROIC) of Corentec Co changed from -12.95 % to 27.59 %, representing a -313.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Corentec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Corentec Co

All Key Metrics — Corentec Co